Change search
ReferencesLink to record
Permanent link

Direct link
Neurologic oral manifestations caused by a new formulation of mirtazapine.
Umeå University, Faculty of Medicine, Integrative Medical Biology, Physiology.
Show others and affiliations
2005 (English)In: Neurology, ISSN 1526-632X, Vol. 65, no 2, 333-4 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 65, no 2, 333-4 p.
Keyword [en]
Administration; Oral, Antidepressive Agents; Tricyclic/administration & dosage/*adverse effects, Dose-Response Relationship; Drug, Extremities/physiopathology, Humans, Ion Channels/drug effects/physiology, Mianserin/administration & dosage/adverse effects/*analogs & derivatives, Mouth/drug effects/physiopathology, Norepinephrine/physiology, Pain/chemically induced/physiopathology, Paresthesia/*chemically induced/physiopathology, Product Surveillance; Postmarketing/*statistics & numerical data, Receptors; Adrenergic/drug effects/physiology, Receptors; Serotonin/drug effects/physiology, Serotonin/physiology, Sweden
URN: urn:nbn:se:umu:diva-12594DOI: doi:10.1212/01.wnl.0000168843.27680.7aPubMedID: 16043818OAI: diva2:152265
Available from: 2008-01-10 Created: 2008-01-10 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Johansson, Staffan
By organisation

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 36 hits
ReferencesLink to record
Permanent link

Direct link